The potential of multi-compound nanoparticles to bypass drug resistance in cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The potential of multi-compound nanoparticles to bypass drug resistance in cancer

Published:2017-09-08 Issue:5 Volume:80 Page:881-894
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Da Silva C. G.,Peters Godefridus J.,Ossendorp Ferry,Cruz Luis J.

Funder

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

FP7 People: Marie-Curie Actions

H2020 Marie Skłodowska-Curie Actions

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-017-3427-1/fulltext.html

Reference141 articles.

1. Da Silva CG, Rueda F, Löwik CW et al (2016) Combinatorial prospects of nano-targeted chemoimmunotherapy. Biomaterials 83:308–320. doi: 10.1016/j.biomaterials.2016.01.006

2. Srinivas M, Tel J, Schreibelt G et al (2015) PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI. Nanomedicine (Lond) 10:2339–2348. doi: 10.2217/NNM.15.76

3. Srinivas M, Cruz LJ, Bonetto F et al (2010) Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. Biomaterials 31:7070–7077. doi: 10.1016/j.biomaterials.2010.05.069

4. Cruz LJ, Stammes MA, Que I et al (2016) Effect of PLGA NP size on efficiency to target traumatic brain injury. J Control Release 223:31–41. doi: 10.1016/j.jconrel.2015.12.029

5. Cruz LJ, Que I, Aswendt M et al (2016) Targeted nanoparticles for the non-invasive detection of traumatic brain injury by optical imaging and fluorine magnetic resonance imaging. Nano Res 9:1276–1289. doi: 10.1007/s12274-016-1023-z

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A carrier-free nanovaccine combined with cancer immunotherapy overcomes gemcitabine resistance;Biomaterials;2025-02

2. Gemcitabine Resistant Triple Negative Breast Tumor Derived Mesoporous Silicon Nanovaccine Overcame Drug Resistance;Advanced Functional Materials;2024-09-13

3. Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies;ACS Omega;2024-08-23

4. Cell reprogramming design by transfer learning of functional transcriptional networks;Proceedings of the National Academy of Sciences;2024-03-04

5. Targosomes: Anti-HER2 PLGA nanocarriers for bioimaging, chemotherapy and local photothermal treatment of tumors and remote metastases;Journal of Controlled Release;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3